Kyle R - Search Results

1

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.

Palumbo A, Rajkumar SV, Dimopoulos MA, Richardson PG, San Miguel J, Barlogie B, Harousseau J, Zonder JA, Cavo M, Zangari M, Attal M, Belch A, Knop S, Joshua D, Sezer O, Ludwig H, Vesole D, Bladé J, Kyle R, Westin J, Weber D, Bringhen S, Niesvizky R, Waage A, von Lilienfeld-Toal M, Lonial S, Morgan GJ, Orlowski RZ, Shimizu K, Anderson KC, Boccadoro M, Durie BG, Sonneveld P, Hussein MA; International Myeloma Working Group. Palumbo A, et al. Among authors: kyle r. Leukemia. 2008 Feb;22(2):414-23. doi: 10.1038/sj.leu.2405062. Epub 2007 Dec 20. Leukemia. 2008. PMID: 18094721 Review.

2

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd. Kyle RA, et al. N Engl J Med. 2002 Feb 21;346(8):564-9. doi: 10.1056/NEJMoa01133202. N Engl J Med. 2002. PMID: 11856795 Free article.

3

Current therapy for multiple myeloma.

Rajkumar SV, Gertz MA, Kyle RA, Greipp PR; Mayo Clinic Myeloma, Amyloid, and Dysproteinemia Group. Rajkumar SV, et al. Among authors: kyle ra. Mayo Clin Proc. 2002 Aug;77(8):813-22. doi: 10.4065/77.8.813. Mayo Clin Proc. 2002. PMID: 12173715 Review.

4

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma.

Rajkumar SV, Hayman S, Gertz MA, Dispenzieri A, Lacy MQ, Greipp PR, Geyer S, Iturria N, Fonseca R, Lust JA, Kyle RA, Witzig TE. Rajkumar SV, et al. Among authors: kyle ra. J Clin Oncol. 2002 Nov 1;20(21):4319-23. doi: 10.1200/JCO.2002.02.116. J Clin Oncol. 2002. PMID: 12409330 Clinical Trial.

5

Bone marrow angiogenesis in multiple myeloma: effect of therapy.

Kumar S, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Greipp PR, Rajkumar SV. Kumar S, et al. Among authors: kyle ra. Br J Haematol. 2002 Dec;119(3):665-71. doi: 10.1046/j.1365-2141.2002.03871.x. Br J Haematol. 2002. PMID: 12437642 Free article.

6

Myeloma and the newly diagnosed patient: a focus on treatment and management.

Rajkumar SV, Kyle RA, Gertz MA. Rajkumar SV, et al. Semin Oncol. 2002 Dec;29(6 Suppl 17):5-10. doi: 10.1053/sonc.2002.34070. Semin Oncol. 2002. PMID: 12520478 Review.

7

Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma.

Kumar S, Gertz MA, Dispenzieri A, Lacy MQ, Geyer SM, Iturria NL, Fonseca R, Hayman SR, Lust JA, Kyle RA, Greipp PR, Witzig TE, Rajkumar SV. Kumar S, et al. Among authors: kyle ra. Mayo Clin Proc. 2003 Jan;78(1):34-9. doi: 10.4065/78.1.34. Mayo Clin Proc. 2003. PMID: 12528875

8

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.

Hahn T, Wingard JR, Anderson KC, Bensinger WI, Berenson JR, Brozeit G, Carver JR, Kyle RA, McCarthy PL Jr. Hahn T, et al. Among authors: kyle ra. Biol Blood Marrow Transplant. 2003 Jan;9(1):4-37. doi: 10.1053/bbmt.2003.50002. Biol Blood Marrow Transplant. 2003. PMID: 12533739 Free article. Review.

9

Monoclonal gammopathies of undetermined significance.

Kyle RA, Rajkumar SV. Kyle RA, et al. Rev Clin Exp Hematol. 2002 Sep;6(3):225-52. doi: 10.1046/j.1468-0734.2002.00076.x. Rev Clin Exp Hematol. 2002. PMID: 12616697 Review.

10

Monoclonal gammopathies of undetermined significance: a review.

Kyle RA, Rajkumar SV. Kyle RA, et al. Immunol Rev. 2003 Aug;194:112-39. doi: 10.1034/j.1600-065x.2003.00056.x. Immunol Rev. 2003. PMID: 12846812 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,841 results

Search Page

Filters